基因组测试将如何影响临床医生的治疗慢性髓性白血病的选择?
Jessica Sia1, Naranie Shanmuganathan1,2,3,4
1Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia.
Expert review of hematology
|July 10, 2025
概括
慢性髓性白血病 (CML) 的基因组分析揭示了影响预后和治疗的遗传多样性. 识别其他突变,如ASXL1和基因重组,对于个性化治疗和改善CML患者的治疗结果至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 慢性髓性白血病 (CML) 是通过特定的分子异常来定义的.
- 氨酸激酶抑制剂已经改变了CML的治疗方法,但耐药性和进展仍然是挑战.
- 基因组分析揭示了CML异质性,为个性化医学提供了潜力.
研究的目的:
- 审查CML的基因组概况的原始文献.
- 探索额外的基因组异常对预后和治疗反应的影响.
- 突出基因变异在CML管理中的重要性.
主要方法:
- 对研究CML基因组概况的文献综述.
- 对体变异的预后和治疗影响的分析.
- 检查CML中的基因重组和融合.
主要成果:
- 像ASXL1这样的基因体变异具有预后和潜在的治疗意义.
- 包括下一代测序在内的基因组分析对新诊断的和进展的CML有价值.
- 基因重组和融合可能表明不良预后风险.
结论:
- 在CML中基因组分析可以帮助风险分层和个性化治疗策略.
- 建议进行早期和重复的基因组测试,以获得最佳的CML管理.
- 检测各种基因组异常对于改善CML患者的治疗结果至关重要.
更多相关视频
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
10.1K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.7K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K